S. Aardal

1.6k total citations
22 papers, 1.2k citations indexed

About

S. Aardal is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, S. Aardal has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in S. Aardal's work include Nitric Oxide and Endothelin Effects (6 papers), Respiratory Support and Mechanisms (6 papers) and Sepsis Diagnosis and Treatment (5 papers). S. Aardal is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Respiratory Support and Mechanisms (6 papers) and Sepsis Diagnosis and Treatment (5 papers). S. Aardal collaborates with scholars based in Norway, Sweden and United States. S. Aardal's co-authors include Karen B. Helle, OWE R. LUHR, Claes Frostell, Kristian Antonsen, Adalbjörn Thorsteinsson, Jan Bonde, Magnus K. Karlsson, G. Serck‐Hanssen, Hans Flaatten and Said Elsayed and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Critical Care and Clinical Microbiology and Infection.

In The Last Decade

S. Aardal

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Aardal Norway 15 499 348 303 199 191 22 1.2k
Richard M. Pino United States 21 225 0.5× 297 0.9× 146 0.5× 39 0.2× 149 0.8× 59 1.5k
R. Neal Garrison United States 19 276 0.6× 120 0.3× 168 0.6× 37 0.2× 58 0.3× 60 1.2k
Michael Farmer Australia 19 285 0.6× 600 1.7× 196 0.6× 55 0.3× 51 0.3× 30 1.3k
M. H. Gee United States 17 520 1.0× 132 0.4× 190 0.6× 25 0.1× 35 0.2× 51 1.1k
I. H. Chaudry United States 15 113 0.2× 153 0.4× 249 0.8× 38 0.2× 35 0.2× 39 936
Γεώργιος Νάκος Greece 15 372 0.7× 197 0.6× 99 0.3× 40 0.2× 22 0.1× 39 920
Chieko Mitaka Japan 20 271 0.5× 246 0.7× 430 1.4× 195 1.0× 11 0.1× 67 1.3k
H Favre Switzerland 26 440 0.9× 758 2.2× 108 0.4× 72 0.4× 86 0.5× 96 1.8k
Sérgio Pinto Ribeiro Canada 10 1.1k 2.2× 475 1.4× 228 0.8× 13 0.1× 120 0.6× 16 1.9k
F. Ulrich Schade Germany 21 155 0.3× 242 0.7× 435 1.4× 30 0.2× 15 0.1× 34 1.3k

Countries citing papers authored by S. Aardal

Since Specialization
Citations

This map shows the geographic impact of S. Aardal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Aardal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Aardal more than expected).

Fields of papers citing papers by S. Aardal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Aardal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Aardal. The network helps show where S. Aardal may publish in the future.

Co-authorship network of co-authors of S. Aardal

This figure shows the co-authorship network connecting the top 25 collaborators of S. Aardal. A scholar is included among the top collaborators of S. Aardal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Aardal. S. Aardal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flaatten, Hans, Guttorm Brattebø, B. Almé, et al.. (2017). Adverse events and in-hospital mortality: an analysis of all deaths in a Norwegian health trust during 2011. BMC Health Services Research. 17(1). 465–465. 15 indexed citations
2.
Bruun, Trond, Bård Reiakvam Kittang, S. Aardal, et al.. (2013). Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway. Clinical Microbiology and Infection. 19(12). E545–E550. 59 indexed citations
3.
Strand, Kristian, Eldar Søreide, S. Aardal, & Hans Flaatten. (2009). A comparison of SAPS II and SAPS 3 in a Norwegian intensive care unit population. Acta Anaesthesiologica Scandinavica. 53(5). 595–600. 29 indexed citations
4.
Flaatten, Hans, et al.. (2005). The effect of tracheostomy on outcome in intensive care unit patients. Acta Anaesthesiologica Scandinavica. 50(1). 92–98. 53 indexed citations
5.
Aardal, S., et al.. (2005). [Medical records, DRG and intensive care patients].. PubMed. 125(7). 903–6. 4 indexed citations
7.
LUHR, OWE R., Kristian Antonsen, Magnus K. Karlsson, et al.. (1999). Incidence and Mortality after Acute Respiratory Failure and Acute Respiratory Distress Syndrome in Sweden, Denmark, and Iceland. American Journal of Respiratory and Critical Care Medicine. 159(6). 1849–1861. 426 indexed citations
8.
Flaatten, Hans, S. Aardal, & Olav Hevrøy. (1998). Improved oxygenation using the prone position in patients with ARDS. Acta Anaesthesiologica Scandinavica. 42(3). 329–334. 31 indexed citations
9.
Helle, Karen B., et al.. (1998). Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery. Scandinavian Journal of Clinical and Laboratory Investigation. 58(8). 625–634. 15 indexed citations
10.
LUHR, OWE R., et al.. (1998). Pulmonary function in adult survivors of severe acute lung injury treated with inhaled nitric oxide. Acta Anaesthesiologica Scandinavica. 42(4). 391–398. 10 indexed citations
11.
LUHR, OWE R., S. Lundin, Carl-Johan Wickerts, et al.. (1997). A retrospective analysis of nitric oxide inhalation in patients with severe acute lung injury in Sweden and Norway 1991–1994. Acta Anaesthesiologica Scandinavica. 41(10). 1238–1246. 5 indexed citations
12.
Aardal, S., N. P. Aardal, R. H. Angeletti, et al.. (1996). Human pheochromocytoma: different patterns of catecholamines and chromogranins in the intact tumour, urine and serum in clinically unsuspected cases. Scandinavian Journal of Clinical and Laboratory Investigation. 56(6). 511–523. 16 indexed citations
13.
Flaatten, Hans, et al.. (1996). Surgery during inhalation with nitric oxide in a patient with severe adult respiratory distress syndrome (ARDS). Acta Anaesthesiologica Scandinavica. 40(3). 376–378. 5 indexed citations
14.
Angeletti, R. H., et al.. (1994). Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A. Acta Physiologica Scandinavica. 152(1). 11–19. 65 indexed citations
15.
Aardal, S., et al.. (1993). Human chromostatin inhibits endothelin-1-induced contractures in human blood vessels. Regulatory Peptides. 47(1). 25–32. 16 indexed citations
16.
Aardal, S., et al.. (1993). Vasostatins, Comprising the N‐terminal Domain of Chromogranin A, Suppress Tension in Isolated Human Blood Vessel Segments. Journal of Neuroendocrinology. 5(4). 405–412. 161 indexed citations
17.
Serck‐Hanssen, G., et al.. (1993). Functional aspects of the adrenal medullary chromogranins. Neurochemistry International. 22(4). 353–360. 18 indexed citations
18.
Aardal, S., Karen B. Helle, & Einar Svendsen. (1992). In vitro Responses to Atrial Natriuretic Polypeptide in Human Vessels Commonly Used as Aortocoronary Bypass Grafts. Scandinavian Journal of Thoracic and Cardiovascular Surgery. 26(2). 135–141. 13 indexed citations
20.
Aardal, S., Magne Bråtveit, & Karen B. Helle. (1990). Differential patterns of relaxation by synthetic atrial peptide (APII) in the pulmonary artery, ascending and distal abdominal aorta. Regulatory Peptides. 28(3). 283–292. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026